Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Farmacosmo And 2 Other Penny Stocks To Watch Closely

In This Article:

As global markets continue to navigate mixed performances, with major U.S. indexes reaching record highs and European markets buoyed by easing political tensions, investors are exploring diverse opportunities. Penny stocks, often associated with smaller or newer companies, remain an intriguing area for those seeking potential growth beyond the well-known market giants. Despite the term's outdated connotations, these stocks can offer a blend of affordability and growth potential when backed by strong financials.

Top 10 Penny Stocks

Name

Share Price

Market Cap

Financial Health Rating

DXN Holdings Bhd (KLSE:DXN)

MYR0.51

MYR2.54B

★★★★★★

Embark Early Education (ASX:EVO)

A$0.79

A$143.12M

★★★★☆☆

Datasonic Group Berhad (KLSE:DSONIC)

MYR0.425

MYR1.18B

★★★★★★

Hil Industries Berhad (KLSE:HIL)

MYR0.90

MYR298.75M

★★★★★★

ME Group International (LSE:MEGP)

£2.16

£806.27M

★★★★★★

Bosideng International Holdings (SEHK:3998)

HK$4.02

HK$44.27B

★★★★★★

LaserBond (ASX:LBL)

A$0.56

A$67.4M

★★★★★★

Lever Style (SEHK:1346)

HK$0.87

HK$545.92M

★★★★★★

Secure Trust Bank (LSE:STB)

£3.53

£67.32M

★★★★☆☆

Tristel (AIM:TSTL)

£3.65

£183.61M

★★★★★★

Click here to see the full list of 5,697 stocks from our Penny Stocks screener.

Let's uncover some gems from our specialized screener.

Farmacosmo

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Farmacosmo S.p.A. operates as an online pharmacy and beauty store company in Italy with a market cap of €25.23 million.

Operations: Farmacosmo S.p.A. does not have reported revenue segments.

Market Cap: €25.23M

Farmacosmo S.p.A., with a market cap of €25.23 million, is navigating the challenges typical of smaller stocks. Despite being unprofitable and experiencing increased losses over five years, it maintains a satisfactory net debt to equity ratio of 15.2% and has sufficient cash runway for over three years. Recent earnings reported sales of €32.89 million for the half year ended June 30, 2024, down from €37.21 million the previous year, with a net loss widening to €1.08 million from €0.37 million previously. The stock trades significantly below its estimated fair value despite high volatility levels.

BIT:COSMO Debt to Equity History and Analysis as at Dec 2024
BIT:COSMO Debt to Equity History and Analysis as at Dec 2024

Sciuker Frames

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Sciuker Frames S.p.A. designs and manufactures wood-aluminum and wood-structural glass windows in Italy, with a market cap of €45.50 million.

Operations: The company generates revenue from its Building Products segment, totaling €119.11 million.